Browse
Submit Data
Databases
API
Help

Dataset Information

8 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-[1-(tert-But-oxy-carbonyl)-pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide.

ABSTRACT: In the title compound, C(16)H(28)N(3)O(4), the plane of the pyrrolidine ring system is twisted with respect to the plane of the nitronyl nitroxide unit, making a dihedral angle of 79.80?(6)°. The crystal structure is stabilized by C-H?O hydrogen bonds.

SUBMITTER: Jiang R

PROVIDER: S-EPMC3007227 | biostudies-other | 2010

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

2-[1-(tert-But-oxy-carbonyl)-pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide.

Jiang Ru R Wang Hai-Bo HB Gao Peng P Jing Lin-Lin LL Sun Xiao-Li XL

Acta crystallographica. Section E, Structure reports online 20100707 Pt 8

In the title compound, C(16)H(28)N(3)O(4), the plane of the pyrrolidine ring system is twisted with respect to the plane of the nitronyl nitroxide unit, making a dihedral angle of 79.80 (6)°. The crystal structure is stabilized by C-H⋯O hydrogen bonds. ...[more]

PMID: 21588278

Similar Datasets

2-[1-(4-Chloro-benzo-yl)pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-imidazole-1-oxyl-3-oxide.

Project description:In the title compound, C(18)H(23)ClN(3)O(3), the imidazole ring system has an envelope conformation, whereas the nitronyl nitroxide unit displays a half-chair or twisted conformation. In the crystal, C-H?O hydrogen bonds build up a three-dimensional network.

| S-EPMC3051528 | biostudies-literature

(R)-2-[1-(2,6-Dichloro-3,4,5-trimeth-oxy-benzo-yl)pyrrolidin-2-yl]-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazole-1-oxyl 3-oxide.

Project description:In the title compound, C(21)H(28)Cl(2)N(3)O(6), the nitronyl nitroxide ring displays a half-chair conformation, whereas the pyrrolidine ring has an envelope conformation. These two rings are twisted to each other with N-C-C-N torsion angles around the connecting C-C bond of 48.9?(6) and -127.0?(5)°. The benzene ring is nearly perpendicular to the pyrrolidine ring, with torsion angles around the connecting C-C bond of 86.3?(6) and -97.7?(6)°. The crystal structure is stabilized by C-H?O and C-H?? hydrogen bonds, which build up a three-dimensional network.

| S-EPMC3099877 | biostudies-other

4,4,5,5-Tetra-methyl-2-[4-(2-pyrid-yl)phen-yl]-3,4-dihydro-imidazole-1-oxyl-3-oxide.

Project description:In the title compound, C(18)H(20)N(3)O(2), the pyridine and phenyl rings are coplanar [dihedral angle = 3.5?(3)°]. The phenyl ring makes a dihedral angle of 29.6?(1)° with the imidazole ring. The crystal structure is stabilized by inter-molecular C-H?O hydrogen bonds.

| S-EPMC2977714 | biostudies-literature

Methyl 2-{[2-(4,4,5,5-tetra-methyl-1,3-dioxyl-4,5-dihydro-imidazol-2-yl)phen-yl]-oxy}acetate.

Project description:In the title compound, C(16)H(21)N(2)O(5), the benzene ring is nearly perpendicular to the imidazole ring, making a torsion angle of 88.6?(8)°·The crystal structure is stabilized by non-classical C-H?O and C-H?? inter-actions, which build up a three-dimensional network.

| S-EPMC3254550 | biostudies-literature

2-[4-(2-Hy-droxy-eth-oxy)phenyl]-4,4,5,5-tetra-methyl-2-imidazoline-1-oxyl 3-oxide.

Project description:In the title compound, C(15)H(21)N(2)O(4), the imidazoline ring displays a twisted conformation. The dihedral angle between the mean plane of the imidazoline ring and the benzene ring is 33.50 (12)°. In the crystal, mol-ecules are connected by O-H⋯O hydrogen bonds, forming a zigzag chain along the c axis. The chains are linked by C-H⋯O and C-H⋯π inter-actions.

| S-EPMC3238993 | biostudies-literature

2-[2-(2-Hy-droxy-eth-oxy)phen-yl]-4,4,5,5-tetra-methyl-2-imidazoline-1-oxyl 3-oxide.

Project description:In the title compound, C(15)H(21)N(2)O(4), the nitronyl nitroxide unit displays a twisted conformation. The crystal structure is stabilized by non-classical C-H?O and C-H?? hydrogen bonds, which build up a three-dimensional network.

| S-EPMC3239125 | biostudies-literature

catena-Poly[[diaqua-cobalt(II)]bis-[?-2-(4-carboxyl-atophen-yl)-4,4,5,5-tetra-methyl-4,5-dihydro-1H-imidazol-1-oxyl 3-oxide]].

Project description:In the title compound, [Co(C(14)H(16)N(2)O(4))(2)(H(2)O)(2)](n), the Co(II) atom, lying on an inversion center, is coordinated by six O atoms in a distorted octa-hedral geometry. The Co(II) atoms are bridged by the nitronyl nitroxide ligands into a tape-like structure along the b axis. The tapes are further connected by O-H?O hydrogen bonds, forming a layer parallel to the bc plane.

| S-EPMC3099874 | biostudies-other

2-(1H-Indol-3-yl)-4,4,5,5-tetra-methyl-imidazolidine-1-oxyl 3-oxide.

Project description:In the title compound, C(15)H(18)N(3)O(2), the plane of the indole ring system is twisted with respect to the plane of the nitronyl nitroxide moiety, exhibiting a dihedral angle of 21.61?(6)°. The crystal packing is stabilized by N-H?O hydrogen bonds and weak C-H?O inter-actions.

| S-EPMC2979679 | biostudies-literature

4,4,5,5-Tetra-methyl-2-(4-pyridinio)-2-imidazoline-1-oxyl-3-oxide perchlorate.

Project description:The crystal structure of the title compound, C(12)H(17)N(3)O(2) (+)·ClO(4) (-), consists of 4,4,5,5-tetra-methyl-2-(4-pyridinio)imidazoline-1-oxyl-3-oxide radical cations and perchlorate anions. Both the cation and the Cl atom of the anion are located on the same twofold rotation axis, and the crystal structure shows the average structure for the radical cation. The five-membered ring assumes a half-chair conformation. The cation links with the anion via N-H?O hydrogen bonding.

| S-EPMC2977742 | biostudies-literature

4,4,5,5-Tetra-methyl-2-(3,4,5-trimethoxy-phen-yl)imidazolidine-1-oxyl 3-oxide.

Project description:In the title nitronyl nitroxide radical compound, C(16)C(23)N(2)O(5), the imidazole and benzene rings are twisted with respect to each other, making a dihedral angle of 26.2 (4)°. The imidazole ring adopts a half-chair conformation. Weak C-H⋯π inter-actions are also found.

| S-EPMC2969929 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data